Plasma Nerve Growth Factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down Syndrome: An interesting pathway

Massimiliano M. Corsi, Giada Dogliotti, Francesca Pedroni, Elisa Palazzi, Paolo Magni, Martina Chiappelli, Federico Licastro

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective: Down's syndrome (DS) is the most frequent chromosomal aberration in men and it is invariably associated with mental retardation. Material and Methods: Plasma levels of nerve growth factor (NGF), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1) from non demented DS subjects of three different age-cohorts (2-14 years; 20-50 yrs; > 60 yrs) and healthy controls were measured. No clinical and sub-clinical inflammation was apparent in DS patients. Results: Plasma levels of NGF were higher in children, adult and old DS subjects than in controls. However, a significant age-related decrease of NGF levels was present in DS subjects. Serum levels of IL-6 and MCP-1 were also increased in DS children and adults, but not in older DS patients. Conclusions: High levels of circulating NGF might protect DS from clinical complications of atherosclerosis. However, the striking decrement of peripheral NGF levels with advancing age may predispose DS to clinical manifestation of dementia after adulthood.

Original languageEnglish
Pages (from-to)773-778
Number of pages6
JournalNeuroendocrinology Letters
Volume27
Issue number6
Publication statusPublished - Dec 2006

Fingerprint

Chemokine CCL2
Nerve Growth Factor
Down Syndrome
Young Adult
Interleukin-6
Cytokines
Chromosome Aberrations
Intellectual Disability
Dementia
Atherosclerosis
Inflammation

Keywords

  • Down's syndrome
  • Interleukin-6
  • Monocyte chemoattractant protein-1
  • Nerve growth factor

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)

Cite this

Plasma Nerve Growth Factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down Syndrome : An interesting pathway. / Corsi, Massimiliano M.; Dogliotti, Giada; Pedroni, Francesca; Palazzi, Elisa; Magni, Paolo; Chiappelli, Martina; Licastro, Federico.

In: Neuroendocrinology Letters, Vol. 27, No. 6, 12.2006, p. 773-778.

Research output: Contribution to journalArticle

Corsi, Massimiliano M. ; Dogliotti, Giada ; Pedroni, Francesca ; Palazzi, Elisa ; Magni, Paolo ; Chiappelli, Martina ; Licastro, Federico. / Plasma Nerve Growth Factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down Syndrome : An interesting pathway. In: Neuroendocrinology Letters. 2006 ; Vol. 27, No. 6. pp. 773-778.
@article{8fd886da1a17483e80b4652c8fbb9cd4,
title = "Plasma Nerve Growth Factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down Syndrome: An interesting pathway",
abstract = "Objective: Down's syndrome (DS) is the most frequent chromosomal aberration in men and it is invariably associated with mental retardation. Material and Methods: Plasma levels of nerve growth factor (NGF), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1) from non demented DS subjects of three different age-cohorts (2-14 years; 20-50 yrs; > 60 yrs) and healthy controls were measured. No clinical and sub-clinical inflammation was apparent in DS patients. Results: Plasma levels of NGF were higher in children, adult and old DS subjects than in controls. However, a significant age-related decrease of NGF levels was present in DS subjects. Serum levels of IL-6 and MCP-1 were also increased in DS children and adults, but not in older DS patients. Conclusions: High levels of circulating NGF might protect DS from clinical complications of atherosclerosis. However, the striking decrement of peripheral NGF levels with advancing age may predispose DS to clinical manifestation of dementia after adulthood.",
keywords = "Down's syndrome, Interleukin-6, Monocyte chemoattractant protein-1, Nerve growth factor",
author = "Corsi, {Massimiliano M.} and Giada Dogliotti and Francesca Pedroni and Elisa Palazzi and Paolo Magni and Martina Chiappelli and Federico Licastro",
year = "2006",
month = "12",
language = "English",
volume = "27",
pages = "773--778",
journal = "Neuroendocrinology Letters",
issn = "0172-780X",
publisher = "Maghira and Maas Publications",
number = "6",

}

TY - JOUR

T1 - Plasma Nerve Growth Factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down Syndrome

T2 - An interesting pathway

AU - Corsi, Massimiliano M.

AU - Dogliotti, Giada

AU - Pedroni, Francesca

AU - Palazzi, Elisa

AU - Magni, Paolo

AU - Chiappelli, Martina

AU - Licastro, Federico

PY - 2006/12

Y1 - 2006/12

N2 - Objective: Down's syndrome (DS) is the most frequent chromosomal aberration in men and it is invariably associated with mental retardation. Material and Methods: Plasma levels of nerve growth factor (NGF), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1) from non demented DS subjects of three different age-cohorts (2-14 years; 20-50 yrs; > 60 yrs) and healthy controls were measured. No clinical and sub-clinical inflammation was apparent in DS patients. Results: Plasma levels of NGF were higher in children, adult and old DS subjects than in controls. However, a significant age-related decrease of NGF levels was present in DS subjects. Serum levels of IL-6 and MCP-1 were also increased in DS children and adults, but not in older DS patients. Conclusions: High levels of circulating NGF might protect DS from clinical complications of atherosclerosis. However, the striking decrement of peripheral NGF levels with advancing age may predispose DS to clinical manifestation of dementia after adulthood.

AB - Objective: Down's syndrome (DS) is the most frequent chromosomal aberration in men and it is invariably associated with mental retardation. Material and Methods: Plasma levels of nerve growth factor (NGF), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1) from non demented DS subjects of three different age-cohorts (2-14 years; 20-50 yrs; > 60 yrs) and healthy controls were measured. No clinical and sub-clinical inflammation was apparent in DS patients. Results: Plasma levels of NGF were higher in children, adult and old DS subjects than in controls. However, a significant age-related decrease of NGF levels was present in DS subjects. Serum levels of IL-6 and MCP-1 were also increased in DS children and adults, but not in older DS patients. Conclusions: High levels of circulating NGF might protect DS from clinical complications of atherosclerosis. However, the striking decrement of peripheral NGF levels with advancing age may predispose DS to clinical manifestation of dementia after adulthood.

KW - Down's syndrome

KW - Interleukin-6

KW - Monocyte chemoattractant protein-1

KW - Nerve growth factor

UR - http://www.scopus.com/inward/record.url?scp=33846432376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846432376&partnerID=8YFLogxK

M3 - Article

C2 - 17187019

AN - SCOPUS:33846432376

VL - 27

SP - 773

EP - 778

JO - Neuroendocrinology Letters

JF - Neuroendocrinology Letters

SN - 0172-780X

IS - 6

ER -